Cancer Research in Low- and Middle-Income Countries: Consortiums, Implementation Science and Healthcare Delivery

Anderson, Benjamin O.

doi:10.1245/s10434-016-5627-z

Cited by 5 publications

(6 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Improving research collaboration between developing and developed countries is generally encouraged to expand enrolling patients to clinical trials. 5 , 7 , 20 It requires adequately advanced research facilities in developing countries to accomplish this task. 20 SA is a strong candidate to play the role model for this collaboration, especially with improved research funding.…”

Section: Discussionmentioning

confidence: 99%

“…As cancer incidence, natural history, and outcomes vary between countries, it is imperative to study cancers in the local population. 5 Furthermore, the engagement of developing countries in oncology research may facilitate research collaboration with developed countries and ultimately improve patient enrollment to clinical trials. 6 However, the availability of oncology research infrastructure in these countries is often limited.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Scholarly Activity of Radiation Oncologists in High-Income Developing Countries: Saudi Arabia as an Example

Alghamdi

Al-Ghamdi

Bahadur

et al. 2021

JCO Global Oncology

View full text Add to dashboard Cite

PURPOSE To examine the trends and quality metrics of publications by radiation oncologists in Saudi Arabia. METHODS PubMed was searched using names of all Saudi radiation oncologists to retrieve published articles between January 2010 and December 2019. International collaboration, journal impact factor and country of origin, and number of citations were collected. Each article was assessed for epidemiologic type and independently assigned a level of evidence (LOE) by two authors. The trend in publications was examined and compared in the first and second 5-year periods (2010-2014 and 2015-2019) using relevant parameters. RESULTS A total of 186 publications were found and included. The most common type of research was cohort studies followed by case reports and case series in 24%, 14%, and 13% of all publications, respectively. Dosimetry, clinical, and preclinical studies formed 7%, 8.6%, and 7.5% of the total publications, respectively. The LOE was I, II, III, IV, and not applicable in 8.6%, 22%, 25.8%, 29%, and 14.5% of the included publications, respectively. Comparing the first and second 5-year periods, there was an increase in international collaboration ( P < .001) in the second period. The number of citations ( P < .001) and journal impact factor ( P = .028) were lower in the second period. LOE and publications in international journals were not statistically different between the two periods. CONCLUSION Although radiation oncology research activity in Saudi Arabia has gained momentum in terms of volume and international collaboration over time, the LOE has not improved. This calls for a national effort to make the contribution to the literature a priority, allocate adequate resources, and apply appropriate measures to enhance research productivity and quality.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Scholarly Activity of Radiation Oncologists in High-Income Developing Countries: Saudi Arabia as an Example

Alghamdi

Al-Ghamdi

Bahadur

et al. 2021

JCO Global Oncology

View full text Add to dashboard Cite

show abstract

“…23 Consortia are small groups with a shared mission and common set of objectives that provide an overarching framework for implementing shared priorities and evidence-based strategies for change. 24 Other strengths of a consortium model include the ability to bring together research expertise and knowledge with service providers from a range of settings, to facilitate communication among consortium members, and to maximise efficiency among partner organisations who together work to understand, prevent and treat illness and disease. 25,26 These strengths resonate with a Wellbeing Economy insofar as both seek to build systems that are collaborative and multisectoral, innovative, responsive and adaptive, while working across boundaries to respond to complex challenges and opportunities.…”

Section: Coordinatingmentioning

confidence: 99%

An Aboriginal‐led consortium approach to chronic disease action for health equity and holistic wellbeing

Morey,

Pearson,

Sivak

et al. 2023

Health Prom J of Aust

View full text Add to dashboard Cite

Issue Addressed The Wellbeing Economy, which places human and ecological wellbeing at the centre of policy making, aligns with holistic Aboriginal and Torres Strait Islander conceptualisations of health and wellbeing. In order to address chronic diseases in South Australian Aboriginal and Torres Strait Islander populations, the South Australian Aboriginal Chronic Disease Consortium (Consortium) is fostering action in ways that align both with the Wellbeing Economy and with Health in All Policies (HiAP) approaches. Methods In June 2017, the Consortium was established as a collaborative partnership between government and non‐government organisations, researchers, Aboriginal organisations and communities to lead the effective implementation of three state‐wide chronic disease plans. A coordinating centre was funded to support and progress the work of the Consortium. Results During its first 5 years, the Consortium has developed a foundation for sustained system reform through partnering with stakeholders, leading projects and initiatives, advocating for key priorities, leveraging existing infrastructure and funding, supporting services, and coordinating delivery of priority actions using innovative approaches. Conclusions Through the Consortium governance structure, Aboriginal and Torres Strait Islander community members, policy actors, service providers and researchers oversee, drive, influence and support the implementation of priority action initiatives. Sustained funding, competing priorities of partner organisations and project evaluation are constant challenges. So What? A consortium approach provides direction and shared priorities, which foster collaboration across and between organisations, service providers and the Aboriginal community. Aligning with HiAP approaches and the Wellbeing Economy, it harnesses knowledge, networks and partnerships that support project implementation and reduce duplication.

show abstract

“…For example, the African Research Group for Oncology linked academic institutions in Nigeria, the US and UK to promote and develop cancer research in Africa. 27 Similar partnerships with ANZ institutions and universities would have the benefits of increasing collaborations and building capacity in the cancer research sector within our region. Developing partnerships in biomedical research such as biobanking and genomics would allow for greater diversity in trial populations, increase our understanding of the genetic and genomic similarities and differences across our region, and help equip local researchers in LMICs to gain the skills required to develop and promote their own research agendas.…”

Section: Capacity Building In Cancer Researchmentioning

confidence: 99%

Australia and New Zealand's responsibilities in improving oncology services in the Asia‐Pacific: A call to action

Wilson

Pokorny

Perera

et al. 2021

Asia-Pac J Clncl Oncology

View full text Add to dashboard Cite

Aim: To review the expected increasing demand for cancer services among low and middle-income countries (LMICs) in the Asia-Pacific (APAC), and to describe ways in which Australia and New Zealand (ANZ) can provide support to improve cancer outcomes in our region. Methods:We first review the current and projected incidence of cancer within the APAC between 2018 and 2040, and the estimated demand for chemotherapy, radiotherapy and surgery. We then explore potential ways in which ANZ can increase regional collaborations to improve cancer outcomes. Results:We identify 6 ways that ANZ can collaborate with LMICs to improve cancer care in the APAC through the ANZ Regional Oncology Collaboration Strategy: 1. Increasing education and institutional collaborations in the APAC region through incountry training, twinning partnerships, observerships and formalised training programs in order to increase cancer care quality and capacity. 2. Promoting and assisting in the establishment and maintenance of population-based cancer registries in LMICs. 3. Increasing research capacity in LMICs through collaboration and promoting high quality global oncology research within ANZ. 4. Engaging and training Australian and New Zealand clinicians in global oncology, increasing awareness of this important career path, and increasing health policy engagement. 5. Increasing web-based endeavours through virtual tumour boards, web-based advocacy platforms and web-based teaching programs. 6. Continuing to leverage for funding through professional bodies, government, industry, not-for-profit organisations and local hospital funds. Conclusion:We propose the creation of an Australian and New Zealand Interest Group to provide formalised and sustained collaboration between researchers, clinicians and stakeholders.

show abstract

Cancer Research in Low- and Middle-Income Countries: Consortiums, Implementation Science and Healthcare Delivery

Abstract: Having caused over 8 million deaths worldwide in 2013, cancer is now the second leading cause of human death.

Cited by 5 publications

References 16 publications

Scholarly Activity of Radiation Oncologists in High-Income Developing Countries: Saudi Arabia as an Example

Scholarly Activity of Radiation Oncologists in High-Income Developing Countries: Saudi Arabia as an Example

An Aboriginal‐led consortium approach to chronic disease action for health equity and holistic wellbeing

Australia and New Zealand's responsibilities in improving oncology services in the Asia‐Pacific: A call to action

Contact Info

Product

Resources

About